QA: Avadel Pharmaceuticals PLC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001012477_2020_Avadel_Pharmaceuticals_PLC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001012477, Avadel Pharmaceuticals PLC

  xvar xval
0 AssetsCurrent 82,380,000
1 IntangibleAssetsNetIncludingGoodwill 19,304,000
2 PropertyPlantAndEquipmentNet 544,000
3 remainder_Assets 49,208,000
4 LiabilitiesCurrent 35,984,000
5 LiabilitiesNoncurrent 132,878,000
6 remainder_Liabilities 11,773,000
7 CostOfGoodsAndServicesSold 10,788,060
8 SellingGeneralAndAdministrativeExpense -22,969,452
9 ResearchAndDevelopmentExpense 32,705,075
10 remainder_Expenses 15,064,755
11 remainder_Revenues 73,662,071
12 remainder_NetIncome 269,964
13 remainder_ComprehensiveNetIncome 510,339
  yvar yval
0 Assets 151,436,000
1 Liabilities 180,635,000
2 Expenses 35,588,438
3 Revenues 73,662,071
4 StockholdersEquity -29,199,000
5 NetIncome 38,343,597
6 ComprehensiveNetIncome 38,598,766
7 BaseVar 221,050,906
8 EconomicCapitalRatiobeforeLimitedLiability -0.151
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution

Change over Time